Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by Barnes Retina Institute.
Recruitment status was  Recruiting
Genentech, Inc.
Information provided by:
Barnes Retina Institute Identifier:
First received: October 17, 2007
Last updated: April 15, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2010
  Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
No publications provided by Barnes Retina Institute

Publications automatically indexed to this study by Identifier (NCT Number):